Rachel Stahler serves as Executive Vice President and Chief Digital & Growth Officer at Organon, a leading global healthcare company focused on improving women's health. In this role, she spearheads the company's digital transformation, growth strategies, and data analytics initiatives, leveraging cutting-edge technologies like AI and machine learning to enhance patient outcomes, optimize operations, and drive sustainable business expansion. Stahler's leadership has been instrumental in positioning Organon at the forefront of digital innovation in women's health, including the development of patient-centric digital platforms and partnerships that accelerate access to treatments for conditions like contraception, menopause, and mental health. With over 20 years of experience in life sciences and consulting, Stahler previously held senior roles at Merck & Co., where she served as Senior Vice President of Digital Strategy & Operations, overseeing global digital capabilities and analytics that supported a portfolio of blockbuster products. Earlier in her career, she was a Partner at McKinsey & Company, advising pharmaceutical and biotech clients on growth strategies, digital health solutions, and operational excellence. Her tenure at McKinsey honed her expertise in transforming complex healthcare ecosystems through data-driven insights and innovative business models. Under Stahler's guidance, Organon has achieved significant milestones, such as launching AI-powered tools for personalized medicine and expanding digital ecosystems that have boosted customer engagement by double digits. A recognized thought leader, she frequently speaks at industry forums on the intersection of digital technology and healthcare equity, championing initiatives that empower women through accessible, tech-enabled care.